XML 20 R29.htm IDEA: XBRL DOCUMENT v2.4.1.9
Note 9 - Collaboration Agreements (Details) - Revenue Recognized from Collaborations (USD $)
In Thousands, unless otherwise specified
3 Months Ended 9 Months Ended
Sep. 30, 2014
Sep. 30, 2013
Sep. 30, 2014
Sep. 30, 2013
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue $ 13,192us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized $ 10,786us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized $ 23,489us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized $ 21,771us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
Collaborative Arrangement [Member] | Milestone Payment [Member] | UniQure [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 14us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_UniQureMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
267us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_UniQureMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
14us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_UniQureMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
267us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_UniQureMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Milestone Payment [Member] | Genetech [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 7,987us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
5,093us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
7,987us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
5,093us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_MilestonePaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Recognition of Upfront Payment [Member] | Teva [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 3,132us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
3,284us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
9,252us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
9,891us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Recognition of Upfront Payment [Member] | Genetech [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 981us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
824us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
2,736us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
2,483us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_RecognitionOfUpfrontPaymentMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Research Funding [Member] | Teva [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 84us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
169us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
251us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
463us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_TevaMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Research Funding [Member] | Genetech [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue 994us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
1,128us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
3,249us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
3,385us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenetechMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
Collaborative Arrangement [Member] | Research Funding [Member] | Genome BC [Member]        
Deferred Revenue Arrangement [Line Items]        
Collaboration Revenue   $ 21us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenomeBCMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember
  $ 189us-gaap_RevenueRecognitionMilestoneMethodRevenueRecognized
/ us-gaap_CounterpartyNameAxis
= xene_GenomeBCMember
/ us-gaap_ResearchAndDevelopmentArrangementContractToPerformForOthersByTypeAxis
= xene_ResearchFundingMember
/ us-gaap_TypeOfArrangementAxis
= us-gaap_CollaborativeArrangementMember